MUSC Oncology Therapeutics

Description:

MUSC Oncology Therapeutics:

Liposomal Delivery of Encapsulated Therapeutics to Treat Pediatric Brain Tumors
http://musc.technologypublisher.com/technology/17463

LSD1 Protein Inhibitors as Epigenetic Modulators
http://musc.technologypublisher.com/technology/15182

Cyclic Peptide Inhibitors of Lysine-Specific Demethylase 1 (LSD1)
http://musc.technologypublisher.com/technology/15181

Chaperone-based Integrin Inhibitors for the Treatment of Cancer and Inflammatory Diseases
http://musc.technologypublisher.com/technology/13451

Antibody Therapeutic for EGFR-expressing Cancers
http://musc.technologypublisher.com/technology/9543

Therapeutic Approach for Combination Cancer Treatments Using Compounds that Block or Interfere with Thromboxane Signaling Pathways
http://musc.technologypublisher.com/technology/18269

Metabolically Stable, Non-Nephrotoxic Puromycin Analogs as Oncology and Anti-infective Therapeutics
http://musc.technologypublisher.com/technology/6654

 

Patent Information:
Category(s):
Therapeutic
For Information, Contact:
Chelsea Ex-Lubeskie
Licensing Manager, Devices
MUSC Foundation for Research Development
843-876-1900
exlubesk@musc.edu
Inventors:
Keywords:
cancer
© 2017. All Rights Reserved. Powered by Inteum